149 related articles for article (PubMed ID: 34060272)
1. Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population.
Lotfaliany M; Hadaegh F; Mansournia MA; Azizi F; Oldenburg B; Khalili D
Int J Health Policy Manag; 2022 Aug; 11(8):1391-1400. PubMed ID: 34060272
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
[TBL] [Abstract][Full Text] [Related]
3. External validation of the American prediction model for incident type 2 diabetes in the Iranian population.
Asgari S; Khalili D; Azizi F; Hadaegh F
BMC Med Res Methodol; 2023 Mar; 23(1):77. PubMed ID: 36991336
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of serum testosterone for type 2 diabetes risk assessment in men.
Atlantis E; Fahey P; Martin S; O'Loughlin P; Taylor AW; Adams RJ; Shi Z; Wittert G
BMC Endocr Disord; 2016 May; 16(1):26. PubMed ID: 27230668
[TBL] [Abstract][Full Text] [Related]
5. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
Chen L; Magliano DJ; Balkau B; Colagiuri S; Zimmet PZ; Tonkin AM; Mitchell P; Phillips PJ; Shaw JE
Med J Aust; 2010 Feb; 192(4):197-202. PubMed ID: 20170456
[TBL] [Abstract][Full Text] [Related]
6. A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study.
Bozorgmanesh M; Hadaegh F; Ghaffari S; Harati H; Azizi F
Eur J Public Health; 2011 Oct; 21(5):554-9. PubMed ID: 20534689
[TBL] [Abstract][Full Text] [Related]
7. Transportability of the updated diabetes prediction model from Atherosclerosis Risk in Communities Study to a Middle Eastern adult population: community-based cohort study.
Bozorgmanesh M; Hadaegh F; Azizi F
Acta Diabetol; 2013 Apr; 50(2):175-81. PubMed ID: 21120544
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of men classified at high-risk for type 2 diabetes mellitus using the AUSDRISK screening tool.
Aguiar EJ; Morgan PJ; Collins CE; Plotnikoff RC; Callister R
Diabetes Res Clin Pract; 2015 Apr; 108(1):45-54. PubMed ID: 25707921
[TBL] [Abstract][Full Text] [Related]
9. The external validity and performance of the no-laboratory American Diabetes Association screening tool for identifying undiagnosed type 2 diabetes among the Iranian population.
Asgari S; Lotfaliany M; Fahimfar N; Hadaegh F; Azizi F; Khalili D
Prim Care Diabetes; 2020 Dec; 14(6):672-677. PubMed ID: 32522438
[TBL] [Abstract][Full Text] [Related]
10. The ARIC predictive model reliably predicted risk of type II diabetes in Asian populations.
Chin CW; Chia EH; Ma S; Heng D; Tan M; Lee J; Tai ES; Salim A
BMC Med Res Methodol; 2012 Apr; 12():48. PubMed ID: 22497781
[TBL] [Abstract][Full Text] [Related]
11. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
[No Abstract] [Full Text] [Related]
14. Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study.
Mozaffary A; Asgari S; Tohidi M; Kazempour-Ardebili S; Azizi F; Hadaegh F
BMJ Open; 2016 May; 6(5):e010889. PubMed ID: 27217283
[TBL] [Abstract][Full Text] [Related]
15. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.
Colagiuri S; Hussain Z; Zimmet P; Cameron A; Shaw J;
Diabetes Care; 2004 Feb; 27(2):367-71. PubMed ID: 14747215
[TBL] [Abstract][Full Text] [Related]
16. Identifying Africans with undiagnosed diabetes: Fasting plasma glucose is similar to the hemoglobin A1C updated Atherosclerosis Risk in Communities diabetes prediction equation.
Mugeni R; Hormenu T; Hobabagabo A; Shoup EM; DuBose CW; Sumner AE; Horlyck-Romanovsky MF
Prim Care Diabetes; 2020 Oct; 14(5):501-507. PubMed ID: 32173292
[TBL] [Abstract][Full Text] [Related]
17. San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study.
Bozorgmanesh M; Hadaegh F; Zabetian A; Azizi F
Int J Public Health; 2010 Aug; 55(4):315-23. PubMed ID: 20217177
[TBL] [Abstract][Full Text] [Related]
18. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
[TBL] [Abstract][Full Text] [Related]
19. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.
Asgari S; Moosaie F; Khalili D; Azizi F; Hadaegh F
J Transl Med; 2020 Jul; 18(1):267. PubMed ID: 32615996
[TBL] [Abstract][Full Text] [Related]
20. External Validation of Finnish Diabetes Risk Score and Australian Diabetes Risk Assessment Tool Prediction Models to Identify People with Undiagnosed Type 2 Diabetes: A Cross-sectional Study in Iran.
Mahmoodzadeh S; Jahani Y; Najafipour H; Sanjari M; Shadkam-Farokhi M; Shahesmaeili A
Int J Endocrinol Metab; 2022 Oct; 20(4):e127114. PubMed ID: 36714189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
